Phendimetrazine

In the US, Phendimetrazine (phendimetrazine systemic) is a member of the following drug classes: anorexiants, CNS stimulants and is used to treat Obesity.

US matches:

• Phendimetrazine


• Phendimetrazine Sustained-Release Capsules


• Phendimetrazine Tartrate


• Phendimetrazine Tablets

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0000634-03-7

Chemical Formula

C12-H17-N-O

Molecular Weight

191

Therapeutic Categories

Central stimulant

Anorexic agent

Chemical Name

Morpholine, 3,4-dimethyl-2-phenyl-, (2S-trans)-

Foreign Names

• Phendimetrazinum (Latin)
• Phendimetrazin (German)
• Phendimétrazine (French)
• Fendimetrazina (Spanish)

Generic Names

• Fendimetrazina (OS: DCIT)
• Phendimetrazine (OS: BAN)
• Phendimétrazine (OS: DCF)
• McN-R 747-11 (IS)
• Phenimethoxazine (IS)
• Sedafamen (IS)
• Phendimetrazine Tartrate (PH: USP 32)

Brand Names

• Adipost
  Jones, United States



• Bontril
  Valeant, United States



• Melfiat
  Numark, United States



• Obex-LA
  Adcock Ingram Pharmaceuticals, South Africa



• Phendimetrazine Tartate
  Actavis, United States; Amide, United States; Hyrex, United States; Mikart, United States; Sandoz, United States



• X-Trozine
  Shire, United States

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.